Ascendia to Highlight CDMO Services at AAPS PharmSci360

Oct 7, 2021 12:00:00 AM

Development and Scale Up Considerations for Nanosuspension Dosage Forms

Sep 13, 2021 12:00:00 AM

How to Successfully Utilize ASDs for Drug Delivery of Insoluble Drugs

Aug 20, 2021 12:00:00 AM

Top Considerations When Developing Formulations for Injectable Solutions

Aug 11, 2021 12:00:00 AM

Considerations in Development and Manufacturing of Complex Injectables for Early Phase Studies

Aug 3, 2021 12:00:00 AM

Top CDMO Companies: Why Bigger Isn’t Always Better

Aug 2, 2021 12:00:00 AM

5 Novel Techniques for Solubility Enhancement

Jul 26, 2021 12:00:00 AM

Ascendia Chief Business Officer Robert Bloder to Sit on CDMO Panel at CPhI North America

Jul 26, 2021 12:00:00 AM

Ascendia to Highlight How to Make Insoluble Soluble During CPhI North America

Jul 20, 2021 12:00:00 AM

cGMP vs GMP: What’s the Difference?

Jul 19, 2021 12:00:00 AM

CDMO Selection Criteria: 4 Factors to Consider

Jul 12, 2021 12:00:00 AM

Formulation Forum: Nanosuspension Dosage Forms

Jul 6, 2021 12:00:00 AM